Navigation Links
MSU's discovery of plant protein holds promise for biofuel production
Date:8/15/2008

EAST LANSING, Mich. Scientists at Michigan State University have identified a new protein necessary for chloroplast development. The discovery could ultimately lead to plant varieties tailored specifically for biofuel production.

Chloroplasts, which are specialized compartments in plant cells, convert sunlight, carbon dioxide and water into sugars and oxygen ("fuel" for the plant) during photosynthesis. The newly discovered protein, trigalactosyldiacylglycerol 4, or TGD4, offers insight into how the process works.

"Nobody knew how this mechanism worked before we described this protein," said Christoph Benning, MSU professor of biochemistry and molecular biology. "This protein directly affects photosynthesis and how plants create biomass (stems, leaves and stalks) and oils."

Benning also is a member of the Great Lakes Bioenergy Research Center, a partnership between MSU and the University of Wisconsin-Madison funded by the U.S. Department of Energy to conduct basic research aimed at solving some of the most complex problems in converting natural materials to energy.

The research, published in the August 2008 issue of journal The Plant Cell, shows how TGD4 is essential for the plant to make chloroplasts. Plants that don't have the protein die before they can develop beyond the embryonic stage.

Understanding how TGD4 works may allow scientists to create plants that would be used exclusively to produce biofuels, possibly making the process more cost-effective. Most plants that are used to produce oils corn, soybeans and canola, for example accumulate the oil in their seeds.

"We've found that if the TGD4 protein is malfunctioning, the plant then accumulates oil in its leaves," Benning said. "If the plant is storing oil in its leaves, there could be more oil per plant, which could make production of biofuels such as biodiesel more efficient. More research is needed so we can completely understand the mechanism of operation."


'/>"/>

Contact: Jamie DePolo
depolo@msu.edu
609-354-8403
Michigan State University
Source:Eurekalert

Related biology news :

1. GIANT-Coli: A novel method to quicken discovery of gene function
2. Life Sciences Discovery Fund awards health research project grants
3. Open access to large-scale drug discovery data
4. Discovery of a mechanism that regulates cell movement
5. Mobilizing white blood cells to the lung: New discovery could lead to an improved influenza vaccine
6. Insect warning colors aid cancer and tropical disease drug discovery
7. Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery
8. New discovery proves selfish gene exists
9. UC Davis researcher leads climate-change discovery
10. New discovery on role of vital protein that fights meningitis
11. University of Arizona scientist shares in discovery of microbe filaments power
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... , June 23, 2016 ... research report to its pharmaceuticals section with historic ... details and much more. Complete report ... 151 pages, profiling 15 companies and supported with ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global ...
Breaking Biology Technology: